|
Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
 
|
2/2025
vol. 100 Review paper
Amplatzer occluders – a breakthrough in the interventional treatment of congenital heart defects. 27 years of experience
Jacek Białkowski
1, 2
,
Małgorzata Szkutnik
1, 2
Pediatr Pol 2025; 100 (2): 157-160
Online publish date: 2025/05/29
Article file
- Amplatzer occluders (1).pdf
[1.23 MB]
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
1. Bialkowski J, Szkutnik M. The use of Amplatzer devices in the percutaneous treatment of congenital heart defects in children and adults based on own experience. Kardiol Pol 2021; 79: 1130-1132. 2.
Bialkowski J, Kusa J, Szkutnik M, et al. Percutaneous catheter closure of atrial septal defect. Short -term and mid-term results (in Spanish). Rev Esp Cardiol 2003; 56: 383-388. 3.
Bialkowski J. Percutaneous closure of atrial septal defect type II – a few remarks on the basis of my own experience. Kardiol Pol 2017; 75: 1062-1063. 4.
Baruteau AE, Hascoet S, Malekzadeh-Milani S, et al. Transcatheter closure of Superior Sinus Venosus defects. JACC 2023; 16: 2587-2599. 5.
Kusa J, Skierska A, Olczak Z. Perutaneous closure of superior venous atrial septal defect with partial pulmonary anomalous venous drainage: an option also for children. Polish Heart J 2024; 82: 339-340. 6.
Knop M, Bialkowski J, Szkutnik M, et al. Transcatheter closure of atrial septal defects type 2 in children under three years of age. Kardiol Pol 2018; 76: 1257-1262. 7.
Majunke N, Bialkowski J, Wilson N, et al. Closure of atrial septal defect with the Amplatzer septal occluders in adults. Am J Cardiol 2009;103: 550-554. 8.
Kirchenko A, Benson LN, Burrows P, et al. Angiographic classification of the isolated persistently patent ductus arteriosus and implication for percutaneous catheter occlusion. Am J Cardiol 1989; 63: 877-880. 9.
Philip R, Walter III BR, Agraval V, et al. Morphologic characterization of the patent ductus arteriosus in the premature infant and the choice of transcatheter occlusion device. Cathet Cardiovasc Interv 2016; 87: 310-317. 10.
Galeczka M, Szkutnik M, Bialkowski J, et al. Transcatheter patent ductus arteriosus closure: what can learned after 25 years? A single centre experience with 1036 patients. Kardiol Pol 2021; 79: 287-293. 11.
Bialkowski J, Fiszer R, Knop M, Glowacki J, Pawlak Sz, Szkutnik M. Short- and long term outcomes of transcatheter ventricular septal defect using different devices in pediatric and adult patients: a single center experience. Pol Heart J 2024; 82: 889-891. 12.
Bialkowski J, Fiszer R, Hrapkowicz T, et al. Ultra-long term histopathological work up of Amplatzer muscular septal defect occluders after surgical removal of the heart due to heart transplantation. Pol Heart J 2025; 83: 85-86. 13.
Walsh MA, Bialkowski J, Szkutnik M, Pawelec-Wojtalik M, Bobkowski W, Walsh KP. Atrioventricular block after transcatheter closure of perimembranous ventricular septal defects. Heart 2006; 92: 1295-1297 14.
Szkutnik M, Quereshi SA, Kusa J, Rosenthal E, Bialkowski J. Use of the Amplatzer muscular ventricular septal occluder for closure of perimembranous ventricular septal defects. Heart 2006; 98: 249-253. 15.
Graham TP. Year in cardiology series. The year in congenital heart diseases. JACC 2007; 50: 368-377. 16.
Tzikas A, Ibrahim R, Velasco-Sanchez D, et al. Transcatheter closure of perimembranous ventricular septal defect with the Amplatzer membranous VSD occluder 2: initial world experience and one-year follow-up. Catheter Cardiovasc Interv 2014; 83: 571-580. 17.
Szkutnik M, Bialkowski J, Dymitrov L, Kaneva A, Lazarov S, Tsonzarova M. Problems that occured during and after transcatheter closure of muscular VSD in two patients. Post Kardiol Interw 2009; 5: 58-61. 18.
Tandir IC, Baspinar O, Saygi M, et al. Use of Liftech Konar-MF, a device for both perimembranous and muscular ventricular septal defects. A multicenter study. Int J Cardiol 2020; 1: 43-50. 19.
Solana-Garcia R, Mendoza-Soto A, Carrasco-Moreno JI, et al. Spanish registry of percutaneous VSD closure with NitOcclud Le VSD Coil: lessons learned after more than a hundred implants. Rev Esp Cardiol 2021; 74: 591-601. 20.
Fiszer R, Galeczka M, Smolka G, et al. Multicentre short- and medium-term report on the device closure of a post-myocardial infarction ventricular septal rupture – in search of risk factors for early mortality. Intern J Cardiol 2024; 401: 131820. 21.
Bialkowski J. Scholarship program for transcatheter treatment of congenital heart defects at Silesian Center for Heart Diseases, Zabrze, Poland and other places for foreign interventional cardiologist. Wiad Lek 2021;74: 2016-2017. 22.
Bialkowski J. Different aspects of Polish-Ukrainian medical cooperation. Cardiol Vasc Res 2021; 5: 1-2. 23.
Bialkowski J. Pediatric cardiology in Poland 2019. Kardiol Pol 2020; 78: 950-951.
Copyright: © 2025 Polish Society of Paediatrics. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
|
POLSKI
